All In Biotech

Drug Trial Radar · NCT05502146

Comparison of Two Different Norepinephrine Bolus Doses for Management of Spinal Anesthesia-Induced Maternal Hypotension

Comparison of Two Different Norepinephrine Bolus Doses for Management of Spinal Anesthesia-Induced Hypotension in Cesarean Section: A Randomized Controlled Study

Last checked: Nov 19, 2026Latest source record: Jan 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

200

Actual

Start

Aug 17, 2022

Primary completion

Oct 1, 2022

Study completion Oct 1, 2022

Sponsor

Lead sponsor
Mersin UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 16, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 49 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

In this study the investigators will compare two doses of norepinephrine bolus (6 mcg and 8 mcg) in management of maternal hypotensive episode after spinal block during cesarean delivery.

Conditions

  • Spinal Anesthetic Toxicity
  • Hypotension Drug-Induced
  • Cesarean Section Complications

Interventions

  • Noradrenaline BitartrateDrug

    An intravenous bolus of norepinephrine 6 mcg will be administered for management of maternal hypotension.

  • Bupivacaine HydrochlorideDrug

    Subarachnoid block will be performed using Bupivacaine hydrochloride (2.5 mL)

  • Noradrenaline BitartrateDrug

    An intravenous bolus of norepinephrine 8 mcg will be administered for management of maternal hypotension.

  • Bupivacaine HydrochlorideDrug

    Subarachnoid block will be performed using Bupivacaine hydrochloride (2.5 mL)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of successful management of maternal hypotensionTime frame: After spinal anesthesia until the end of surgery
  2. Number of Noradrenaline doses administered and total dose amountTime frame: After spinal anesthesia until the end of surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mersin University

    Mersin, Yenişehir, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.